pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVS
NOVARTIS AG
Phase 1
MRT-8102
Inflammation
$GLUE
Monte Rosa Therapeutics, Inc.
Phase 1
MRX-2843
Non-Small Cell Lung Cancer
Meryx Inc
← prev
page 109 of 231
next →
131
Pain
89
Neurology
1
Phase 1
MRX-8
Acinetobacter Infections
MicuRx Pharmaceuticals Inc
Preclinical
MSC-2
Optic Neuritis
SanBio Co Ltd
Preclinical
MSCKD
Acute Renal Failure (ARF) (Acute Kidney Injury)
Orgenesis Inc
Phase 1
MT-101
Parkinson's Disease
MThera Pharma Co Ltd
Phase 2
MT-125
Glioblastoma Multiforme (GBM)
Myosin Therapeutics Inc
Phase 2
MT-2990
Endometriosis
Tanabe Pharma Corp
Phase 2
MTG-201
Prostate Cancer
Momotaro-Gene Inc
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
Phase 2
MTL-CEBPA
Hepatocellular Carcinoma
Mina Therapeutics Ltd
Phase 2
MTX-001
Venous Leg Ulcers (Crural Ulcer)
Merakris Therapeutics Inc
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
Phase 2
MTX-652
Acute Renal Failure (ARF) (Acute Kidney Injury)
Mission Therapeutics Ltd
MUCINEX DM MAXIMUM STRENGTH
MUCINEX DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE)
no indication
RB HLTH
MUCUS DM
MUCUS DM (DEXTROMETHORPHAN HBR, GUAIFENESIN)
no indication
PERRIGO R AND D
MUCUS RELIEF DM MAXIMUM STRENGTH
MUCUS RELIEF DM MAXIMUM STRENGTH (GUAIFENESIN AND DEXTROMETHORPHAN HBR)
no indication
AUROBINDO PHARMA
Preclinical
MUL-001
Neurofibromatoses Type II
Mulberry Biotherapeutics Inc
MULTIHANCE
MULTIHANCE (GADOBENATE DIMEGLUMINE)
no indication
BRACCO
MULTIPLE ELECTROLYTES PH 5.5
MULTIPLE ELECTROLYTES PH 5.5 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE)
no indication
FRESENIUS KABI USA
Phase 2
MVAmBN-396
Eastern Equine Encephalitis
Bavarian Nordic AS
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
Preclinical
MVP-0601
Malignant Pleural Mesothelioma
OncoVITA SAS
Preclinical
MVREX-101
Wounds
Immvira Co Ltd
Preclinical
MVREX-104
Androgenic Alopecia
Immvira Co Ltd
Preclinical
MVREX-107
Pulmonary Fibrosis
Immvira Co Ltd
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
Phase 2
MVX-220
Angelman Syndrome
Mavrix Bio LLC
Phase 2
MWTx-01
Polycythemia Vera
$IRON
Disc Medicine, Inc.
